Search information pages
About AIDS Research and Therapy
This page includes information about the aims and scope of AIDS Research and Therapy, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
AIDS Research and Therapy is an open access, peer reviewed journal publishing basic science and clinically important research articles to help abate the spread of AIDS.
The journal is edited by Kailash C. Gupta with the assistance of an expert Editorial Board, including Deputy Editors Greg T. Spear (united States), Ramesh Akkina (United States), Jintanat Ananworanich (Thailand) and Gita Ramjee (South Africa).
AIDS Research and Therapy aims to publish articles on basic preclinical, clinical, social, epidemiological and behavioral sciences as well as education research articles that help in abating the spread and burden of AIDS. AIDS Research and Therapy publishes articles on novel and developing treatment strategies for AIDS, as well as on the outcomes of established treatment strategies. Original research articles on animal models that form an essential part of the AIDS treatment research are also published. The ultimate goal of the journal's focus is to lead bench research to bedside practice to combat AIDS. AIDS is spreading at alarming rates in several African and Asian countries. Thus, any development that occurs in combating AIDS should be disseminated as rapidly as possible through the world. AIDS Research and Therapy is a multidisciplinary journal that aims to keep scientists and clinicians globally abreast of the latest research on HIV-1 and AIDS.
All articles published by AIDS Research and Therapy are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
Authors of articles published in AIDS Research and Therapy are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. AIDS Research and Therapy therefore levies an article-processing charge of £1295/$2205/€1640 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
All articles published in AIDS Research and Therapy are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in AIDS Research and Therapy include:
- Global Health
- Google Scholar
- Index Copernicus
- Journal Citation Reports/Science Edition
- PubMed Central
- Science Citation Index Expanded
The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).
The full text of all research articles published by BioMed Central is also available on SpringerLink.
AIDS Research and Therapy is tracked by Thomson Reuters (ISI) and has an Impact Factor of 1.78.
Publication and peer review process
Criteria for Publication
AIDS Research and Therapy considers the following types of articles:
- Research - reports of data from original research.
- Case reports - reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. All case report articles should be accompanied by written and signed consent to publish the information from the patients or their guardians.
- Hypotheses - short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence.
- Methodology articles - present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available.
- Reviews - comprehensive, authoritative descriptions of any subject within the journal's scope. These are usually written by opinion leaders invited by the Editorial Board.
- Short reports - brief reports of data from original research.
Peer review policy
All manuscripts submitted to AIDS Research and Therapy will be peer reviewed. Each manuscript will be sent to the appropriate Section Editor who in turn will assign 3 reviewers (other members of the Editorial Board or outside experts) with the stipulation that the review must be submitted within 2 weeks. Once two concordant reviews are received, the Section Editor will make a decision, even if the third review has not been received. In the case of conflicting reviews, the Section Editor will have the prerogative on making a decision. In general, if two of three reviews are favourable, the manuscript will be accepted. However, if two are not favourable it will be declined. Any properly challenged decision will be given due consideration by the Section Editor and the Editor-in-Chief.
Edited by Kailash C Gupta, AIDS Research and Therapy is supported by an expert Editorial Board.
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My AIDS Research and Therapy, a personalized section of the site.
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
AIDS Research and Therapy will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.
All manuscripts submitted to AIDS Research and Therapy should adhere to BioMed Central's editorial policies.
Citing articles in AIDS Research and Therapy
Articles in AIDS Research and Therapy should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. AIDS Res Ther [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. AIDS Res Ther 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in AIDS Research and Therapy?
AIDS Research and Therapy's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
AIDS Research and Therapy offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through AIDS Research and Therapy, BioMed Central and PubMed Central and will also be included in PubMed.
Online publication in AIDS Research and Therapy gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in AIDS Research and Therapy are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on AIDS Research and Therapy's pages and on the BioMed Central homepage.
In addition, articles published in AIDS Research and Therapy may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in AIDS Research and Therapy. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of articles published in AIDS Research and Therapy retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.